Treatment with anti-TNF-α antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis

By Kageyama Yasunori   Takahashi Masaaki   Torikai Eiji   Suzuki Motohiro   Ichikawa Tetsuya   Nagafusa Tetsuyuki   Koide Yukio   Nagano Akira  

Clinical Rheumatology, Vol. 26, Iss. 4, 2007-04 ,pp. : 505-509

Springer Publishing Company

Access to resources Recommend Favorite

Pneumocystis jirovecii pneumonia: a rare but serious complication during TNF inhibitor treatment for rheumatoid arthritis in Japan

By Miyasaka Nobuyuki   Harigai Masayoshi  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 4, 2013-08 ,pp. : 425-426

Future Medicine

Access to resources Recommend Favorite

The changes in serum chemokines following leflunomide therapy in patients with rheumatoid arthritis

By Klimiuk Piotr   Kita Jacek   Chwiecko Justyna   Sierakowski Stanislaw  

Clinical Rheumatology, Vol. 28, Iss. 1, 2009-01 ,pp. : 17-21

Springer Publishing Company

Access to resources Recommend Favorite

The serum concentration of infliximab in cases of autologous blood donation for patients with rheumatoid arthritis

By Mochizuki Takeshi   Momohara Shigeki   Ikari Katsunori   Okamoto Hiroshi   Kobayashi Shu   Tsukahara So   Iwamoto Takuji   Kawamura Koichiro   Saito Seiji   Tomatsu Taisuke  

Modern Rheumatology, Vol. 17, Iss. 1, 2007-02 ,pp. : 24-27

Springer Publishing Company

Access to resources Recommend Favorite

Histological changes in bone marrow after treatment of infliximab for rheumatoid arthritis

By Kanbe Katsuaki   Inoue Kazuhiko   Inoue Yasuo   Suzuki Yutaka  

Clinical Rheumatology, Vol. 27, Iss. 4, 2008-04 ,pp. : 497-501

Springer Publishing Company

Access to resources Recommend Favorite